0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessThe need for repeated treatment of restenosis of a treated vessel remains the main limitation of percutaneous coronary revascularization. Because sirolimus (rapamycin) inhibits the proliferation of lymphocytes and smooth-muscle cells, we compared a sirolimus-eluting stent with a standard uncoated stent in patients with angina pectoris.
Marie‐Claude Morice, Patrick W. Serruys, J. Eduardo Sousa, Jean Fajadet, Ernesto Ban Hayashi, Marco Perin, Antonio Colombo, Gerhard Schüler, Paul Barragan, Giulio Guagliumi, Ferenc Molnár, Robert Falotico (2002). A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization. New England Journal of Medicine, 346(23), pp. 1773-1780, DOI: 10.1056/nejmoa012843.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2002
Authors
12
Datasets
0
Total Files
0
Language
English
Journal
New England Journal of Medicine
DOI
10.1056/nejmoa012843
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
